Listing 1 - 5 of 5 |
Sort by
|
Choose an application
Lymphomas. --- Skin --- Germinoblastomas --- Immunoblastomas --- Lymphoma --- Non-Hodgkin's lymphoma --- Reticulolymphosarcomas --- Sarcoma, Germinoblastic --- Sarcoma, Immunoblastic --- Lymphoproliferative disorders --- Reticulo-endothelial system --- Tumors. --- Tumors
Choose an application
This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of lymphoma subtypes. Lymphoma includes:.: Details the most current management across the spectrum of lymphoma subtypes; Expert contributors from across the US and Canada; Multidisciplinary coverage and emphasis on emerging therapeutic options, cutting edge developments and clinical research with near-term potential in clinical management. Series Description:. Emerging Cancer Therapeutics is an invited review publication providing a thorough analysis of key clinical research relat
Lymphomas. --- Stem cells --- Stem cell transplantation --- Cell transplantation --- Germinoblastomas --- Immunoblastomas --- Lymphoma --- Non-Hodgkin's lymphoma --- Reticulolymphosarcomas --- Sarcoma, Germinoblastic --- Sarcoma, Immunoblastic --- Lymphoproliferative disorders --- Reticulo-endothelial system --- Transplantation. --- Tumors
Choose an application
Macrophages are tissue resident phagocytes that have important roles in development and immunity. The observation that cancers become infiltrated by large numbers of macrophages was first made by Virchow in 1863, clinical and experimental studies suggest tumor-associated macrophages (TAM) are critical to promote carcinogenesis and tumor-progression, however to this day it still isn’t clear what regulates the recruitment of macrophages in tumors and what drives their pro-tumor functions. This volume will provide an overview of current research on the form and function of TAM, highlighting both the mechanistic roles they play in carcinogenesis and tumor progression as well as the molecular mechanisms that control their phenotype and function, and the final chapter addresses the issue of TAM as a potential target in cancer therapy.
Cancer -- Research. --- Macrophages. --- Tumors. --- Macrophages --- Tumors --- Immunology --- Cancer --- Disease Attributes --- Mononuclear Phagocyte System --- Phagocytes --- Connective Tissue Cells --- Myeloid Cells --- Diseases --- Cells --- Immune System --- Pathologic Processes --- Anatomy --- Pathological Conditions, Signs and Symptoms --- Hemic and Immune Systems --- Neoplasms --- Disease Progression --- Biology --- Medicine --- Health & Biological Sciences --- Oncology --- Microbiology & Immunology --- Growth --- Immunological aspects --- Tumours --- Histiocytes --- Mononuclear phagocytes --- Medicine. --- Cancer research. --- Pharmacology. --- Biomedicine. --- Cancer Research. --- Pharmacology/Toxicology. --- Pathology --- Cysts (Pathology) --- Antigen presenting cells --- Connective tissue cells --- Killer cells --- Reticulo-endothelial system
Choose an application
Lymphomas and leukemias of the nervous system result in devastating neurological complications and high mortality. These malignancies may arise within the central nervous system or may disseminate to the brain or cerebrospinal fluid from a source elsewhere in the body. Early diagnosis and therapeutic intervention lead to improvement in neurological symptoms and signs and potentially improved survival. The diagnostic evaluation and treatment of lymphoma and leukemia of the nervous system differ from the standard approaches used when the disease is confined outside of the nervous system. Lymphoma and Leukemia of the Nervous System is a comprehensive review of this challenging group of diseases and should be useful for the practicing neurologist, hematologist, oncologist and for any practitioner involved in the management of these patients. Review of the first edition This book, the first devoted primarily to the disease (Primary CNS Lymphoma), provides a comprehensive source for the study of the clinical features, diagnostic aspects, and approaches of lymphoma treatment. Although the main focus of the book is primary central nervous system lymphoma, several contributing authors also provide high-quality chapters on the neurologic manifestations of non-Hodgkin's lymphoma, Hodgkin's disease, and plasma-cell disorders and the neurologic complications of lymphoma therapy. This book — up-to-date, concise, and clearly written — provides a review of the disease that is more in-depth than that found even in subspecialty textbooks. Joachim Yahalom, M.D., Department of Radiation Oncology Memorial Sloan-Kettering Cancer Center New England Journal of Medicine.
Nervous system -- Cancer. --- Nervous system -- Tumors. --- Lymphomas --- Leukemia --- Nervous system --- Lymphoproliferative Disorders --- Neoplasm Invasiveness --- Nervous System Neoplasms --- Neoplasms by Histologic Type --- Nervous System --- Neoplastic Processes --- Immunoproliferative Disorders --- Nervous System Diseases --- Neoplasms --- Anatomy --- Neoplasms by Site --- Lymphatic Diseases --- Hemic and Lymphatic Diseases --- Diseases --- Immune System Diseases --- Pathologic Processes --- Pathological Conditions, Signs and Symptoms --- Leukemic Infiltration --- Lymphoma --- Central Nervous System Neoplasms --- Central Nervous System --- Medicine --- Health & Biological Sciences --- Oncology --- Tumors --- Lymphomas. --- Leukemia. --- Cancer. --- Leucaemia --- Leucemia --- Leucocythaemia --- Leucocythemia --- Leucosis --- Leukaemia --- Leukosis --- Germinoblastomas --- Immunoblastomas --- Non-Hodgkin's lymphoma --- Reticulolymphosarcomas --- Sarcoma, Germinoblastic --- Sarcoma, Immunoblastic --- Medicine. --- Cancer research. --- Pharmacology. --- Biomedicine. --- Cancer Research. --- Pharmacology/Toxicology. --- Anemia --- Cancer --- Leucocytosis --- Preleukemia --- Lymphoproliferative disorders --- Reticulo-endothelial system --- Oncology. --- Toxicology. --- Chemicals --- Pharmacology --- Poisoning --- Poisons --- Toxicology --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemotherapy --- Drugs --- Pharmacy --- Cancer research --- Physiological effect
Choose an application
Granulocyte colony-stimulating factor (G-CSF or GCSF) is a secreted glycoprotein that stimulates the proliferation and differentiation of granulocyte precursor cells, and induces mobilization of peripheral blood progenitor cells from the bone marrow. Development of recombinant human G-CSF has had a profound impact on the treatment of many diseases, including severe chronic neutropenia and cancer, and has enabled peripheral stem cell transplantation to supplant bone marrow transplantation in the autologous setting. This Milestones in Drug Therapy volume describes the experience of the last 20 years of treatment with recombinant human G-CSF, including the basic science, the use of recombinant human G-CSF in both the oncology and nononcology settings, and the safety and economics of its use. Many of the authors were the original investigators of recombinant human G-CSF and other authors are key researchers who provide their outlook for the next 20 years for use of and research with recombinant human G-CSF.
Drug abuse -- Etiology -- Handbooks, manuals, etc. --- Drug abuse -- Psychological aspects -- Handbooks, manuals, etc. --- Filgrastim --- Colony-Stimulating Factors --- Leukemia --- Neoplasms, Plasma Cell --- Receptors, Colony-Stimulating Factor --- Lymphoproliferative Disorders --- Hematologic Diseases --- Hemostatic Disorders --- Therapeutics --- Paraproteinemias --- Hemorrhagic Disorders --- Hematopoietic Cell Growth Factors --- Receptors, Cytokine --- Immunoproliferative Disorders --- Neoplasms by Histologic Type --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Receptors, Growth Factor --- Hemic and Lymphatic Diseases --- Blood Protein Disorders --- Glycoproteins --- Vascular Diseases --- Cytokines --- Proteins --- Receptors, Peptide --- Neoplasms --- Receptors, Immunologic --- Diseases --- Immune System Diseases --- Cardiovascular Diseases --- Receptors, Cell Surface --- Amino Acids, Peptides, and Proteins --- Intercellular Signaling Peptides and Proteins --- Membrane Proteins --- Chemicals and Drugs --- Biological Factors --- Peptides --- Multiple Myeloma --- Granulocyte Colony-Stimulating Factor --- Drug Therapy --- Leukocyte Disorders --- Leukemia, Myeloid --- Receptors, Granulocyte Colony-Stimulating Factor --- Health & Biological Sciences --- Biology --- Pharmacy, Therapeutics, & Pharmacology --- Microbiology & Immunology --- Granulocyte-macrophage colony-stimulating factor. --- Colony-stimulating factors (Physiology) --- Granulocytes. --- Macrophages. --- Histiocytes --- Mononuclear phagocytes --- Granular leucocytes --- CSF-GM (Colony-stimulating factor) --- GM-CSF (Colony-stimulating factor) --- Histamine-producing cell-stimulating factor --- Medicine. --- Cancer research. --- Immunology. --- Pharmacology. --- Hematology. --- Cytokines. --- Growth factors. --- Biomedicine. --- Pharmacology/Toxicology. --- Cancer Research. --- Cytokines and Growth Factors. --- Antigen presenting cells --- Connective tissue cells --- Killer cells --- Phagocytes --- Reticulo-endothelial system --- Leucocytes --- Hematopoietic growth factors --- Toxicology. --- Oncology. --- Haematology --- Internal medicine --- Blood --- Cellular immunity --- Immune response --- Immunobiology --- Life sciences --- Serology --- Tumors --- Chemicals --- Medicine --- Pharmacology --- Poisoning --- Poisons --- Regulation --- Toxicology --- Cell growth factors --- Cellular growth factors --- Growth peptides --- Growth promoting substances --- Growth substances --- Peptide growth factors --- Peptide regulatory factors --- Polypeptide growth factors --- Cancer research --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemotherapy --- Drugs --- Pharmacy --- Physiological effect
Listing 1 - 5 of 5 |
Sort by
|